496 related articles for article (PubMed ID: 18452749)
1. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
Mayer NH; Whyte J; Wannstedt G; Ellis CA
Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
[TBL] [Abstract][Full Text] [Related]
3. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity.
Chen JJ; Wu YN; Huang SC; Lee HM; Wang YL
Arch Phys Med Rehabil; 2005 Aug; 86(8):1655-60. PubMed ID: 16084822
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
7. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
9. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.
Lee HM; Chen JJ; Wu YN; Wang YL; Huang SC; Piotrkiewicz M
Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
11. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
Kong KH; Neo JJ; Chua KS
Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
[TBL] [Abstract][Full Text] [Related]
13. Botulinum treatment for post-stroke spasticity: low dose regime.
Viriyavejakul A; Vachalathiti R; Poungvarin N
J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073
[TBL] [Abstract][Full Text] [Related]
14. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
15. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin-A injections for spastic toe clawing.
Lim EC; Ong BK; Seet RC
Parkinsonism Relat Disord; 2006 Jan; 12(1):43-7. PubMed ID: 16198612
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity.
Kawamura A; Campbell K; Lam-Damji S; Fehlings D
Dev Med Child Neurol; 2007 May; 49(5):331-7. PubMed ID: 17489805
[TBL] [Abstract][Full Text] [Related]
20. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
Turner-Stokes L; Ashford S
Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
